To further determine the effect of NLRC3 on CD8+ T cell infiltration in the tumor-bearing mouse models, we established the Hepa1-6-sh-NC-bearing and Hepa1-6-shRNA1-bearing models and analyzed them by FACs on day 16 (as shown in Figure 4A). This evidence concerns the gene NLRC3 and neoplasm.